psoriatic arthritis

Photo of four hands going up for a rebound as a basketball floats above the rim
Biotech

Acelyrin rebounds with psoriatic arthritis victory

Acelyrin's fate rests heavily on lead asset izokibep, with new psoriatic arthritis data expected to reinstall confidence in the program.
Max Bayer Mar 11, 2024 10:59am
detective gumshoe film noir mystery

Fierce Biotech Bureau of Investigations seeks ACR poster burglar

Nov 16, 2023 12:59pm
money trend loss dollar stock down

Ventyx stock drops 70% as TYK2 inhibitor psoriasis plans halted

Nov 7, 2023 7:23am
Moon Lake

MoonLake shines brighter as IL-17 drug scores latest phase 2 win

Nov 6, 2023 8:14am
race cars race competition

Acelyrin brings total raised in 1 year past past $500M mark

Sep 13, 2022 10:05am